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ABSTRACT 
Background 
Family history is an established risk factor for breast cancer.  Although some important genetic 
factors have been identified, the extent to which familial risk can be attributed to genetic factors 
versus common environment remains unclear. 
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Methods 
We estimated the familial concordance and heritability of breast cancer among 21,054 monozygotic 
and 30,939 dizygotic female twin pairs from the Nordic Twin Study of Cancer, the largest twin 
study of cancer in the world. We accounted for left-censoring, right-censoring, as well as the 
competing risk of death. 
Results 
From 1943 through 2010, 3,933 twins were diagnosed with breast cancer. The cumulative lifetime 
incidence of breast cancer taking competing risk of death into account was 8.1% for both zygosities, 
while the cumulative risk for twins whose co-twins had breast cancer was 28% among monozygotic 
and 20% among dizygotic twins. The heritability of liability to breast cancer was 31% (95% CI 
10% - 51%) and the common environmental component was 16% (95% CI 10% - 32%). For pre-
menopausal breast cancer these estimates were 27% and 12%, respectively and for postmenopausal 
breast cancer 22% and 16%, respectively. The relative contributions of genetic and environmental 
factors were constant between ages 50 and 96. Our results are compatible with the Peto-Mack 
hypothesis. 
Conclusion  
Our findings indicate that familial factors explain almost half of the variation in liability to develop 
breast cancer, and results were similar for pre- and post-menopausal breast cancer 
Impact 
We estimate heritability of breast cancer, taking until now ignored sources of bias into account.
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INTRODUCTION 
Although much is known about the causes of breast cancer, the role of genetic factors remains 
incompletely understood(1, 2).  In 2000 Lichtenstein and colleagues reported that 27% of the 
variation underlying breast cancer liability in a Nordic twin cohort could be explained by genetic 
factors(3). Today a number of specific genes have been identified that account for approximately 
30% of the familial risk(4). The largest specific gene effects are associated with the BRCA1/2 
which accounts for about 16% of the total familial risk(5). 
Traditional twin studies to date have largely ignored issues of censoring and competing risk of 
death in estimating the genetic contribution to risk(3, 6). This can lead to severe bias in the 
estimates for incidence, risk concordance and heritability. In our analysis of the Nordic Twin Study 
of Cancer (NorTwinCan) data, we handle these issues by utilizing recently developed statistical 
methods(7). The purpose of this study is to conduct a refined investigation of the familial risk of 
breast cancer using the world’s largest twin study of cancer. Our data have been expanded beyond 
those analyzed by Lichtenstein and colleagues(3) through the addition of the Norwegian twin 
cohorts and the inclusion of 14 to 16 additional years of follow-up for the Danish, Finnish and 
Swedish twin cohorts. Besides estimating the familial risk of breast cancer in monozygotic and 
dizygotic twin pairs by determining the cumulative incidence and casewise concordance, we also 
estimate the heritability of risk and of liability for breast cancer, and examine age differences in the 
familial risk of developing breast cancer. Peto and Mack hypothesized a pattern of constant 
incidence over age for cotwins of twins diagnosed with breast cancer(1), which we investigate. 
Additionally, we estimate heritability for pre- and post-menopausal cancer separately. These results 
provide a useful reference for genome wide association studies as well as for further studies on the 
etiology of breast cancer.  
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MATERIALS AND METHODS 
The twin cohorts 
This study is based on the population-based NorTwinCan database, consisting of the Danish(8), 
Finnish(9), Norwegian(10) and Swedish(11, 12) twin registries combined with data from the 
national cancer and mortality registries. In this database each twin has a personal identity code, 
which includes information on sex and birth date, and enables combination of twin, cancer and 
mortality information. Characteristics of the four twin cohorts are summarized in Table 1. Zygosity 
in the twin registries was determined by validated questionnaires, which are known to classify more 
than 95% of pairs of twins correctly(13). We restrict genetic analyses in the present study to same-
sexed female twin pairs with known zygosity(9-13) as opposite-sex twin pairs require different 
methods and have been studied specifically in a recent study(14). The ethical committees for each 
country approved the study.  
Statistical analyses 
We followed the approaches used by Scheike and colleagues(15, 16) which extend classical 
methods of twin data analysis to correct for censoring and competing risk of death during follow-
up, when studying breast cancer risk in a twin, given breast cancer in the co-twin. We have 
previously described these methods in a study of prostate cancer(17). If neither censoring nor 
competing risk of death were present then our results would agree with those obtained from the 
standard quantitative genetic models of twin data(18, 19). Our modelling distinguished three 
possible outcomes. A twin could either be (a) diagnosed with cancer, (b) die before end of follow 
up, without being diagnosed with breast cancer, or (c) be censored by either being lost to follow up, 
mostly due to emigration (<2%) or surviving without breast cancer until end of follow-up. Times of 
entry and end of follow-up were defined for each country (Table 1). Both twins in a pair are 
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followed up the same time, and can hence be assumed censored at the same time except if one twin 
emigrated, in which case we artificially censored the cotwin. 
We estimated the casewise concordances in MZ and DZ pairs, both overall and by age. This 
provides a measure of the risk of developing breast cancer conditional on the cotwin being 
diagnosed with breast cancer. As we have almost full ascertainment in this study, the casewise 
concordance will equal the probandwise concordance used in some other studies. Moreover, we 
calculated the multilocus index as a measure of non-additive effects of multiple risk loci(20, 21), To 
investigate pre-menopausal cancer we only considered as cases those with a diagnosis before age 
50, while for investigating post-menopausal cancer, we only considered as cases those with a 
diagnosis after or at age 53, considering diagnosis at an earlier age as competing risk. Those ages 
were chosen as the median age of menopause has been estimated to be around 51 years, with some 
variation(22). 
The biometric ACE model was used to estimate additive genetic (A), common environment (C) 
and unique individual effects (E) explaining the variation in liability of breast cancer(18, 19). MZ 
twins are genetically identical at the sequence level, therefore A effects are perfectly correlated in 
MZ pairs. In contrast, DZ twins are genetically as similar as siblings, which corresponds to a 
correlation of 0.5 for A effects. Common environmental effects (C) are assumed to be equal and 
correlate 1.0 in all pairs regardless of zygosity. Hence a higher concordance between MZ twins 
compared to DZ twins indicates a genetic effect. If the C effects that influence variance in the 
liability to develop breast cancer are more correlated among members of MZ than DZ pairs this 
would lead to an overestimation of A, and if they were less correlated among members of MZ than 
DZ pairs this would lead to an underestimation of A. The E component is assumed to be 
independent within twin pairs. In addition, using the Akaike information criterion, we checked 
whether alternative models that included a dominant genetic effect (D) instead of the additive 
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genetic or common environment effect, improved the fit of the model. Doing this we took into 
account that models containing a D component, without an A component would be biologically 
implausible, hence mainly checking the fit of an ADE model. 
We used a liability threshold model to estimate the variance components, as well as the 
cumulative incidence and casewise concordance, both overall and by age. We tested for equal 
cumulative risk of cancer between MZ and DZ twins, and compared this risk with risk estimates 
calculated by the non-parametric Aalen-Johansen estimator(23). For these estimates we used the 
maximum age in the dataset (slightly above 100 years) as the endpoint of the lifetime risk. We 
investigated if country or birth year should be added as covariates. As the age at diagnosis was used 
as the time scale in the time to event models, it was automatically taken into account in the non-
parametric baseline hazard. 
Furthermore, we investigated the pattern suggested by Peto and Mack of breast cancer incidence 
in patients’ relatives(1), by plotting cumulative hazard of breast cancer diagnosis stratified by age of 
onset in the cotwin, taking account for censoring and competing risk of deaths. 
The statistical software R(24) was used with the package mets(16, 25), etm(23), mvna(26) and 
prodlim(27) for all analyses. 
 RESULTS 
The NorTwinCan cohort comprises 104,539 women from same-sexed twin pairs of known zygosity 
of whom 3,933 were diagnosed with breast cancer through 2010 at the latest (Table 1). Restricting 
to complete pairs, there were 3,911 cases of breast cancer diagnosed among 42,110 MZ and 61,880 
DZ twins, i.e. among 51,995 pairs. Of these 124 MZ and 141 DZ pairs were concordant for breast 
cancer.  
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The cumulative incidence of breast cancer over the life span was 8.1% and did not differ 
between MZ and DZ twins. Table 2 presents the lifetime risk of disease, casewise concordances for 
disease risk by zygosity, and the genetic and common environmental variance components 
underlying variation in breast cancer liability. These results reveal a considerably increased risk of 
breast cancer among women whose co-twin had breast cancer.  This familial effect is substantially 
greater among MZ than DZ pairs.  
Figure 1 shows the casewise concordance of breast cancer. At every age, breast cancer risk among 
DZ twins whose co-twin had breast cancer was higher compared to the overall cumulative 
incidence. Moreover, the breast cancer risk for a MZ twin given that her co-twin was already 
diagnosed was 1.5 times higher than the corresponding concordance risk for DZ pairs. The relative 
recurrence risk was higher in MZ than in DZ pairs (Table 3).  The multilocus index provided no 
clear indication of genetic heterogeneity for breast cancer, with estimates non-significantly different 
from 2. The relative recurrence risk for both MZ and DZ twins was higher at younger ages, while 
the multilocus index was relatively stable by age. 
Fitting the biometric models adjusting for censoring and competing risk, the ACE model fitted 
best; neither the A nor the C could be dropped without significantly worsening the fit. The ACE 
model indicated about 31% heritability and 16% common environment effect. Adding the year of 
birth or country as covariate did not change the ACE-heritability estimates.  
Figure 2 shows the magnitude of the additive genetic and common environmental variance 
components of breast cancer liability by age at diagnosis derived from the biometric ACE 
modelling. It appears that the size of those components does not differ between 60 and almost 100 
years of age.  
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Among concordant twin pairs, there were slight and non-significant zygosity differences in the 
time between the diagnosis of breast cancer in the first and second twin. The mean difference was 
11.8 years (SE 0.80) for concordant MZ pairs and 11.7 years (SE 0.83) for concordant DZ pairs (p-
value 0.92). Figure 3 shows the cumulative hazard of breast cancer dependent on the cotwin’s age at 
diagnosis, stratified by zygosity. A later cancer occurrence in a twin, if the cotwin was diagnosed at 
a higher age is visible in the figure, both for MZ and DZ twins. Although this pattern is present for 
MZ as well as DZ twins, it is much stronger for MZ, with an early diagnosis in the cotwin being 
associated with earlier and higher hazard for  the twin. The Peto-Mack hypothesis(1) would predict 
parallel curves for higher ages in Figure 3, a pattern which is not violated in this study.  
We investigated post-menopausal breast cancer separately and observed casewise concordances 
of 21% in MZ and 16% in DZ pairs. Moreover, the common environment component was estimated 
to be 16% while the heritability was 22% (Table 2). For pre-menopausal breast cancer we observed 
a concordance of 10% in MZ and 6% in DZ pairs resulting in a common environment estimate of 
12% and heritability of 27% (Table 2). Hence, pre-menopausal breast cancer seems to have a 
slightly higher genetic contribution than post-menopausal breast cancer, and slightly lower common 
environment contributions. 
We also looked into metachronous bilateral breast cancer as described by Hartmann et al.(28), 
defined as two diagnoses of breast cancer in the same woman at least 3 months apart. In the 
NorTwinCan cohort there were 5 MZ twins with bilateral breast cancer, four of these concordant 
with a cotwin who had only one breast cancer diagnosis. There were 3 DZ twins with bilateral 
breast cancer, all from pairs discordant for any breast cancer. 
Finally, the NorTwinCan cohort contains 98,841 men with known zygosity from same-sex twin 
pairs. Of those 17 were diagnosed with breast cancer during follow-up, consisting of 7 MZ and 10 
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DZ twins. None of those were concordant for breast cancer with their cotwin, and we have not 
conducted further analyses on the data from the male twins. 
DISCUSSION 
Results from this large, population-based and virtually complete cohort of Nordic twins provide 
evidence that genetic differences between women explain a substantial portion of the variation 
(31%) in liability to develop breast cancer. Moreover, among DZ twins who are as genetically 
similar as siblings, the lifetime probability of developing breast cancer if the co-twin had cancer is 
around 20% which is twice the lifetime risk in the general population. Our study also provides new 
insights regarding the importance of genetic effects across age of diagnosis. Specifically, the 
relative contribution of genetic factors was similar across the age groups, while the effect of 
common environment drops slightly in the older group.  
There are several strengths of the current study which extend the work by Lichtenstein and 
colleagues(3). Our study includes more than twice the number of pairs and breast cancer events, one 
additional country, new birth cohorts and more than 10 years of additional follow-up. We accounted 
for varying follow-up time, problems of censoring, and competing causes of death(3).  We 
estimated the genetic component of variation in liability to develop breast cancer to be 31% (95% 
CI 10%-52%), which is similar to that reported by Lichtenstein and colleagues of 27% (95% CI 
4%–41%)(3). However, our study provides novel insight into the variation across age for measures 
of risk and liability of breast cancer diagnosis. Namely, although the heritability estimates are 
similar, our incorporation of competing risk of death and censoring revealed that the lifetime 
cumulative incidence of breast cancer is lower (8.1%) as  compared to the 75 year incidences of 
13% for MZ and 9% in DZ as reported earlier(3). 
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Our analyses assume that the probability of screening among co-twins is independent of 
zygosity. However, if an MZ co-twin is more likely to be screened than a DZ co-twin of a 
diagnosed twin, the genetic component might be inflated due to overdiagnosis(29), but in that case 
we would have observed a higher incidence of breast cancer in the MZ than the DZ twins. 
However, MZ twins had only a 0.3% higher incidence than DZ twins in all countries, and therefore 
differential screening seems unlikely. The lack of difference in incidence between MZ and DZ 
twins is consistent with the assumption that the causes (genetic and environmental) of breast cancer 
do not differ by twin type. Other uncontrolled co-factors as education or health behavior could also 
influence the results, if they would differ by zygosity, but earlier studies indicate no large 
differences between MZ and DZ twins(30-33). 
It has been reported previously that casewise concordance in DZ twins may increase with 
age(1), As expected we detect a similar pattern in our data, but taking prevalence by age into 
account, the relative recurrence risk is greatest among younger women and decreases slightly with 
age in MZ and DZ pairs while the corresponding multilocus index appears to be stable across age.    
Moreover, our investigation of the age of diagnosis, depending on the cotwin’s age at diagnosis 
shows an association, both for MZ and DZ twins, with an earlier diagnosis in the cotwin being 
associated with an earlier diagnosis and higher incidence in the twin. This pattern is, consistent with 
heritable risks, much stronger in MZ than in DZ twins. Our results are consistent with the 
hypothesis of constant hazard at higher ages by Peto and Mack(1) although they only predicted the 
dependency on age of diagnosis of the cotwin  for DZ twins, while we find evidence of it for MZ 
twins as well. 
Twin studies provide context for genome wide association studies, which have identified 
multiple risk loci for breast cancer incidence(4). The multilocus index, being less than two and 
on November 17, 2015. © 2015 American Association for Cancer Research. cebp.aacrjournals.org Downloaded from 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 
Author Manuscript Published OnlineFirst on November 10, 2015; DOI: 10.1158/1055-9965.EPI-15-0913 
12 
 
stable across age, suggests an additive effect of multiple genes. The index in breast cancer is lower 
than that observed in prostate cancer(17). Our estimates of total heritability make it possible to 
determine the extent to which breast cancer variability is explained by risk loci known today. The 
concept of missing heritability has been proposed to describe the discrepancy between the variance 
in cancer associated with identified genetic loci and total heritability(34, 35) and as only 30% of the 
familial risk can be explained by known genes(4) a large amount of the heritable risk found in this 
study remains unexplained by known genetic risk factors . A recent study on height and BMI 
indicates that much of the missing heritability in those cases can be explained by a large number of 
small genetic effects not detected as significant in current genome-wide association studies 
(GWAS)(36), a similar pattern could explain the missing heritability of breast cancer. 
In summary, heritability does not provide an estimate directly translatable to public health 
policy(37). It does, however, provide insight into individual differences in susceptibility to develop 
breast cancer, framing results from genome wide association studies and missing heritability. 
Estimates of the shared risk of breast cancer between MZ twins, who have identical genomes, 
provide an upper limit of the potential for genotyping and whole-genome sequencing to classify 
individuals’ risk(35, 37, 38). Finally, casewise concordance among DZ twins can help us to assess 
the cancer risk of first degree relatives in families affected by breast cancer. 
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Table 1. Description of female twins from same-sexed pairs in the Nordic Twin Studies of Cancer 
(NorTwinCan) Cohorts 
 Denmark Finland Norway Sweden Total 
Birth cohorts 1870-2004 1880-1957 1895-1979 1886-2008  
Cancer registration since 1943 1953 1953 1958  
Initiation of Follow-Up 1943 1975 1964 1961  
End of Follow-up 2009-12-31 2010-12-31 2008-12-31 2009-12-31  
N female twins 33,339 12,507 12,824 45,869 104,539 
N MZ/DZ complete pairs 6,235/10,430 2,026/4,179 2,935/3,439 9,859/12,892 21,055/30,940
N MZ/DZ complete  
uncensored pairs 
1,251/2,332 403/792 195/232 1,781/3,238 3,630/6,594 
N breast cancer cases 1,229 635 358 1,711 3,933 
N breast cancer in 
complete pairs 
1,229 630 352 1,700 3,911 
N breast cancer in 
complete uncensored 
pairs 
695 
 
221 91 907 1,914 
N concordant uncensored 
MZ/DZ pairs 
44/48 15/23 13/5 52/65 124/141 
N discordant uncensored 
MZ/DZ pairs 
170/341 39/106 18/37 243/430 470/914 
N unaffected uncensored 
MZ/DZ pairs 
1,037/1,943 349/663 164/190 1,486/2,743 3,036/5,539 
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Table 2. Cumulative risk, casewise concordance risk and heritability of liability to breast cancer 
diagnosis in the NorTwinCan database. Bias-correction due to censoring by the inverse probability 
weighting technique. Lifetime risk for premenopausal cancer is up to 50 years while lifetime risk 
for post-menopausal cancer is conditional on survival to age 53 years. 
 Lifetime risk 
and 95% CI 
Casewise concordance and 
95% CI 
Estimates and 95% CIs from 
twin modeling  
Age at 
diagnosis 
 MZ DZ Common 
env. c2 
Heritability 
h2 
Any ages 8.1% 
(7.8%, 8.5%) 
28% 
(23%, 33%) 
20% 
(17%, 24%) 
16% 
(10%, 32%) 
31% 
(10%, 52%) 
<50 years  1.5% 
(1.2%, 1.7%) 
10% 
(5%, 17%) 
6% 
(3%, 10%) 
12% 
(0%, 39%) 
27%  
(0%, 62%) 
≥53 years 7.2% 
(6.6%, 7.8%) 
21% 
(16%, 27%) 
16% 
(13%, 20%) 
16% 
(0%, 34%) 
22% 
(0%, 46%) 
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Table 3. Relative recurrence risk and multilocus index of breast cancer by decades of age of 
diagnosis of breast cancer for female MZ and DZ pairs.  Bias-correction due to censoring and 
competing risk of death.  
Age Relative recurrence 
risk for MZ 
(95% CI) 
 Relative recurrence 
risk for DZ  
(95% CI) 
Multilocus index 
(95% CI) 
All 2.16 (1.77, 2.55) 1.70 (1.41, 1.99) 1.64 (0.78, 2.50) 
-50 5.91 (1.75, 10.07) 3.51 (1.02, 6.00) 1.96 (-0.59, 4.51) 
50-60 4.93 (3.36, 6.50) 2.77 (1.83, 3.71) 2.21 (0.74, 3.68) 
60-70 2.98 (2.27, 3.69) 2.24 (1.73, 2.75) 1.60 (0.74, 2.46) 
70-80 2.50 (2.01, 2.99) 1.80 (1.45, 2.15) 1.87 (0.87, 2.87) 
80-90 2.15 (1.76, 2.54) 1.67 (1.38, 1.96) 1.71 (0.77, 2.65) 
90+ 2.04 (1.65, 2.43) 1.68 (1.39, 1.97) 1.53 (0.65, 2.41) 
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Figure legends: 
Fig 1: Casewise concordance of breast cancer risk by age at diagnosis for MZ pairs and DZ 
pairs, and the marginal risk of breast cancer. The risks are adjusted for censoring and 
competing risk of death. Transparent areas show 95% confidence. 
 
Fig 2: Additive genetic and common environment component of liability to breast cancer by 
age at diagnosis. Bias-correction due to censoring and competing risk of death by the inverse 
probability weighting technique. Transparent areas show 95% confidence. 
 
Fig 3: Pattern of cumulative breast cancer hazard in monozygotic (left) and dizygotic (right) 
twins with respect to age of diagnosis of the cotwin. Bias-correcting due to censoring and 
competing risk. 
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